ACM
MDGL icon

ADAR1 Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

ADAR1 Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$469K Hold
895
– – 0.03% 208
2025
Q4 		$521K Sell
895
-4,000
-82% -$2.04M 0.04% 180
2025
Q3 		$2.25M Buy
4,895
+3,841
+364% +$1.43M 0.22% 73
2025
Q2 		$319K Sell
1,054
-436
-29% -$130K 0.05% 135
2025
Q1 		$494K Buy
+1,490
New +$490K 0.1% 105
2024
Q4 		– Sell
-50
Closed -$10.6K – 271
2024
Q3 		$10.6K Buy
+50
New +$12.8K ﹤0.01% 253
2024
Q1 		– Hold
0
– – – 285
2023
Q4 		– Hold
0
– – – 175

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return